{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T04:28:20Z","timestamp":1786940900635,"version":"build-2736575974"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100013254","name":"National College Students Innovation and Entrepreneurship Training Program","doi-asserted-by":"publisher","award":["202411641029Z"],"award-info":[{"award-number":["202411641029Z"]}],"id":[{"id":"10.13039\/501100013254","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82304275"],"award-info":[{"award-number":["82304275"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019042","name":"Jiangsu Ocean University","doi-asserted-by":"publisher","award":["JOUMIRF008"],"award-info":[{"award-number":["JOUMIRF008"]}],"id":[{"id":"10.13039\/501100019042","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.ejmech.2026.118616","type":"journal-article","created":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T16:47:54Z","timestamp":1769186874000},"page":"118616","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Discovery of 3-indolealkylamines as novel dual-target \u03c31R\/H3R ligands with potent analgesia"],"prefix":"10.1016","volume":"306","author":[{"given":"Xiong","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zong-Zheng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xing-Yu","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Min","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai-Le","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao-Yun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Jing","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tian-Yue","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Niu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Zhuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2026.118616_bib1","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.1016\/S0140-6736(21)00393-7","article-title":"Chronic pain: an update on burden, best practices, and new advances","volume":"397","author":"Cohen","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.ejmech.2026.118616_bib2","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1016\/S0140-6736(19)30352-6","article-title":"Transition from acute to chronic pain after surgery","volume":"393","author":"Glare","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.ejmech.2026.118616_bib3","doi-asserted-by":"crossref","first-page":"2627","DOI":"10.1007\/s00204-021-03068-2","article-title":"Toxicities of opioid analgesics: respiratory depression, histamine release, hemodynamic changes, hypersensitivity, serotonin toxicity","volume":"95","author":"Baldo","year":"2021","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.ejmech.2026.118616_bib4","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1007\/s40264-018-0660-4","article-title":"Comparative rates of mortality and serious adverse effects among commonly prescribed opioid analgesics","volume":"41","author":"Murphy","year":"2018","journal-title":"Drug Saf."},{"key":"10.1016\/j.ejmech.2026.118616_bib5","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1080\/17581869.2024.2442292","article-title":"Novel non-opioid analgesics in pain management","volume":"14","author":"Pulskamp","year":"2024","journal-title":"Pain Manag."},{"key":"10.1016\/j.ejmech.2026.118616_bib6","doi-asserted-by":"crossref","first-page":"3235","DOI":"10.2147\/DDDT.S257494","article-title":"Potential impact of the multi-target drug approach in the treatment of some complex diseases","volume":"14","author":"Makhoba","year":"2020","journal-title":"Drug Des. Dev. Ther."},{"key":"10.1016\/j.ejmech.2026.118616_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2021.106055","article-title":"Polypharmacology: the science of multi-targeting molecules","volume":"176","author":"Kabir","year":"2022","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.ejmech.2026.118616_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2024.117043","article-title":"TRPM8 and TRPA1 ideal targets for treating cold-induced pain","volume":"282","author":"Qi","year":"2025","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118616_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2025.117656","article-title":"Design, synthesis and biological activity of novel pyrimidine piperazine ureas as \u03bc-opioid and TRPV1 dual-target ligands for pain management","volume":"292","author":"Wang","year":"2025","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118616_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2024.116208","article-title":"Novel dual-target FAAH and TRPV1 ligands as potential pharmacotherapeutics for pain management","volume":"267","author":"Qiao","year":"2024","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118616_bib11","doi-asserted-by":"crossref","first-page":"15508","DOI":"10.1021\/acs.jmedchem.0c01127","article-title":"Discovery of EST73502, a dual \u03bc-opioid receptor agonist and \u03c31 receptor antagonist clinical candidate for the treatment of pain","volume":"63","author":"Garc\u00eda","year":"2020","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118616_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.jclinane.2024.111729","article-title":"Reduction of postoperative pain and opioid consumption by VVZ-149, first-in-class analgesic molecule: a confirmatory phase 3 trial of laparoscopic colectomy","volume":"101","author":"Lee","year":"2025","journal-title":"J. Clin. Anesth."},{"key":"10.1016\/j.ejmech.2026.118616_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.114091","article-title":"Dual Sigma-1 receptor antagonists and hydrogen sulfide-releasing compounds for pain treatment: design, synthesis, and pharmacological evaluation","volume":"230","author":"Dichiara","year":"2022","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118616_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113658","article-title":"Bifunctional \u03bc opioid and \u03c31receptor ligands as novel analgesics with reduced side effects","volume":"223","author":"Zhuang","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118616_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113879","article-title":"Optimization of bifunctional piperidinamide derivatives as \u03c31R Antagonists\/MOR agonists for treating neuropathic pain","volume":"226","author":"Xiong","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118616_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbrc.2024.149547","article-title":"Thiophenpiperazine amide derivatives as new dual MOR and \u03c31R ligands for the treatment of pain","volume":"697","author":"Fan","year":"2024","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ejmech.2026.118616_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2024.107921","article-title":"Benzylpiperidine derivatives as new dual \u03bc-opioid and \u03c31 receptor ligands with potent antinociceptive effects","volume":"153","author":"Li","year":"2024","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2026.118616_bib18","doi-asserted-by":"crossref","first-page":"8209","DOI":"10.1021\/jm3011993","article-title":"The \u03c31 receptor antagonist S1RA is a promising candidate for the treatment of neurogenic pain","volume":"55","author":"Wunsch","year":"2012","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118616_bib19","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1517\/17460441.2015.1051961","article-title":"Sigma-1 receptors and animal studies centered on pain and analgesia","volume":"10","author":"Davis","year":"2015","journal-title":"Expet Opin. Drug Discov."},{"key":"10.1016\/j.ejmech.2026.118616_bib20","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/s00011-015-0819-8","article-title":"Sigma-1 receptor and inflammatory pain","volume":"64","author":"Gris","year":"2015","journal-title":"J. Inflamm. Res."},{"key":"10.1016\/j.ejmech.2026.118616_bib21","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1111\/bph.14696","article-title":"Histamine, histamine receptors, and neuropathic pain relief","volume":"177","author":"Obara","year":"2020","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejmech.2026.118616_bib22","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1002\/ejp.1097","article-title":"Effects of S 38093, an antagonist\/inverse agonist of histamine H3 receptors, in models of neuropathic pain in rats","volume":"22","author":"Chaumette","year":"2018","journal-title":"Eur. J. Pain"},{"key":"10.1016\/j.ejmech.2026.118616_bib23","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1080\/13543776.2024.2446227","article-title":"Histamine H3 receptor antagonists\/inverse agonists: a patent review (October 2017\u2013December 2023) documenting progress, Expert Opin","volume":"35","author":"\u0141a\u017cewska","year":"2025","journal-title":"Ther. Pat."},{"key":"10.1016\/j.ejmech.2026.118616_bib24","doi-asserted-by":"crossref","first-page":"2974","DOI":"10.2174\/0929867327666200806103144","article-title":"Dual-targeting approach on histamine H3 and sigma-1 receptor ligands as promising pharmacological tools in the treatment of CNS-linked disorders","volume":"28","author":"Szczepa\u0144ska","year":"2021","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118616_bib25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1021\/acschemneuro.1c00435","article-title":"Structural and molecular insight into piperazine and piperidine derivatives as histamine H3 and sigma-1 receptor antagonists with promising antinociceptive properties","volume":"13","author":"Szczepa\u0144ska","year":"2021","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.ejmech.2026.118616_bib26","doi-asserted-by":"crossref","first-page":"9658","DOI":"10.1021\/acs.jmedchem.3c00430","article-title":"Dual piperidine-based histamine H3 and sigma-1 receptor ligands in the treatment of nociceptive and neuropathic pain","volume":"66","author":"Szczepa\u0144ska","year":"2023","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118616_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2022.106039","article-title":"Discovery of a novel class of benzoxazole derivatives as histamine H3 receptor ligands for the treatment of neuropathic pain","volume":"127","author":"Li","year":"2022","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2026.118616_bib28","doi-asserted-by":"crossref","first-page":"52852","DOI":"10.1039\/C7RA10716A","article-title":"Fischer indole synthesis applied to the total synthesis of natural products","volume":"7","author":"Heravi","year":"2017","journal-title":"RSC Adv."},{"key":"10.1016\/j.ejmech.2026.118616_bib29","doi-asserted-by":"crossref","first-page":"33540","DOI":"10.1039\/D1RA05972F","article-title":"Synthesis of indole derivatives as prevalent moieties present in selected alkaloids","volume":"11","author":"Heravi","year":"2021","journal-title":"RSC Adv."},{"key":"10.1016\/j.ejmech.2026.118616_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2025.117710","article-title":"Discovery of Artesunate (ARS) PROTACs as GPX4 protein degraders for the treatment of bladder cancer","volume":"293","author":"Yang","year":"2025","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118616_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114649","article-title":"Benzylaminofentanyl derivates: discovery of bifunctional \u03bc opioid and \u03c31 receptor ligands as novel analgesics with reduced adverse effects","volume":"241","author":"Zhuang","year":"2022","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118616_bib32","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1038\/nature17391","article-title":"Crystal structure of the human \u03c31 receptor","volume":"532","author":"Schmidt","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2026.118616_bib33","doi-asserted-by":"crossref","first-page":"9809","DOI":"10.1021\/jm400660u","article-title":"Structure of the \u03c31 receptor and its ligand binding site: miniperspective","volume":"56","author":"Brune","year":"2013","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118616_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2021.105411","article-title":"Guided rational design with scaffold hopping leading to novel histamine H3 receptor ligands","volume":"117","author":"Ghamari","year":"2021","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2026.118616_bib35","doi-asserted-by":"crossref","first-page":"6105","DOI":"10.1038\/s41467-022-33880-y","article-title":"Structural basis for recognition of antihistamine drug by human histamine receptor","volume":"13","author":"Peng","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejmech.2026.118616_bib36","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1021\/acsmedchemlett.4c00529","article-title":"Discovery of novel pH-Sensitive \u03bc-Opioid receptor agonists as potent analgesics with reduced side effects","volume":"16","author":"Wang","year":"2025","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2026.118616_bib37","doi-asserted-by":"crossref","first-page":"3869","DOI":"10.2147\/JPR.S385617","article-title":"Potent analgesic action of 2-acetoxy-5-(2-4 (trifluoromethyl)-phenethylamino)-benzoic acid (Flusalazine) in experimental mice","author":"Kim","year":"2022","journal-title":"J. Pain Res."},{"key":"10.1016\/j.ejmech.2026.118616_bib38","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1007\/s00213-023-06329-3","article-title":"Flupirtine and antihistamines exert synergistic anti-nociceptive effects in mice","volume":"240","author":"Chen","year":"2023","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.ejmech.2026.118616_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2023.e14522","article-title":"Comparative analysis between open field and elevated plus maze tests as a method for evaluating anxiety-like behavior in mice","volume":"9","author":"de Figueiredo Cerqueira","year":"2023","journal-title":"Heliyon"},{"key":"10.1016\/j.ejmech.2026.118616_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2025.177919","article-title":"Discovery of two new co-drugs of celecoxib and gabapentinoids for treating chemotherapy-induced peripheral neuropathy","volume":"1003","author":"Yin","year":"2025","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejmech.2026.118616_bib41","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.toxrep.2022.03.013","article-title":"Evaluation of acute and sub-acute toxicity profile of 5-methylcoumarin-4\u03b2-glucoside in mice","volume":"9","author":"Abubakar","year":"2022","journal-title":"Toxicol. Rep."},{"key":"10.1016\/j.ejmech.2026.118616_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2025.118165","article-title":"Microwave-assisted one-pot green synthesis, ADMET profiling, DFT, and molecular docking of novel 3-cyano-2-pyridone derivatives as dual EGFR and cytokine (TNF-\u03b1, IL-6) inhibitors","volume":"300","author":"Lotfy","year":"2025","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118616_bib43","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2025.143767","article-title":"Synthesis, structural characterization, in silico ADMET analysis and quality control of a new process-related impurity in vortioxetine","volume":"1349","author":"Feng","year":"2026","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.ejmech.2026.118616_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2024.116623","article-title":"Synthesis of thiazolidine-2, 4-dione tethered 1, 2, 3-triazoles as \u03b1-amylase inhibitors: in vitro approach coupled with QSAR, molecular docking, molecular dynamics and ADMET studies","volume":"275","author":"Singh","year":"2024","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118616_bib45","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.bbamem.2013.04.028","article-title":"Surface plasmon resonance spectroscopy for characterisation of membrane protein\u2013ligand interactions and its potential for drug discovery","volume":"1838","author":"Patching","year":"2014","journal-title":"BBA-Biomembranes"},{"key":"10.1016\/j.ejmech.2026.118616_bib46","doi-asserted-by":"crossref","first-page":"5701","DOI":"10.1021\/acs.jcim.4c00500","article-title":"Exploring structural requirements for Sigma-1 receptor linear ligands: experimental and computational approaches","volume":"64","author":"Lombardo","year":"2024","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.ejmech.2026.118616_bib47","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115984","article-title":"Structure-based design of potent FABP4 inhibitors with high selectivity against FABP3","volume":"264","author":"Chen","year":"2024","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118616_bib48","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2024.116227","article-title":"Identification of 3-aryl-5-methyl-isoxazole-4-carboxamide derivatives and analogs as novel HIF-2\u03b1 agonists through docking-based virtual screening and structural modification","volume":"268","author":"Chen","year":"2024","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118616_bib49","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.3390\/biomedicines10061413","article-title":"Synergistic antinociceptive effects of indomethacin-pregabalin and meloxicam-pregabalin in paclitaxel-induced neuropathic pain","volume":"10","author":"Ma","year":"2022","journal-title":"Biomedicines"},{"key":"10.1016\/j.ejmech.2026.118616_bib50","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2024.176738","article-title":"The synergistic anti-nociceptive effects of nefopam and gabapentinoids in inflammatory, osteoarthritis, and neuropathic pain mouse models","volume":"977","author":"Xiao","year":"2024","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejmech.2026.118616_bib51","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2023.175870","article-title":"Pregabalin can interact synergistically with Kv7 channel openers to exert antinociception in mice","volume":"954","author":"Huang","year":"2023","journal-title":"Eur. J. Pharmacol."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523426000619?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523426000619?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T05:32:37Z","timestamp":1771911157000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523426000619"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":51,"alternative-id":["S0223523426000619"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2026.118616","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Discovery of 3-indolealkylamines as novel dual-target \u03c31R\/H3R ligands with potent analgesia","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2026.118616","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"118616"}}